Level of toll-like receptor agonist exposure differentially determines chemokine production in humans

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 7, 2007, Pages 739-746

  Lissitsyn, Yuriy ^a   Becker, Allan B ^a   Kozyrskyj, Anita L ^a   HayGlass, Kent T ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Chemokine; Toll like receptor; Toll like receptor agonist

Indexed keywords

CHEMOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHOOL CHILD;

ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL22; CHEMOKINES; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PEPTIDOGLYCAN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 35648948967     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-064     Document Type: Conference Paper

References (60)

1. Adcock, I.M., and Caramori, G. 2004. Chemokine receptor inhibitors as a novel option in treatment of asthma. Curr. Drug Targets Inflamm. Allergy, 3: 257-261. doi:10.2174/1568010043343660.
2. Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., et al. 2003. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171: 4984-4989.
3. Akira, S., and Takeda, K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. doi:10.1038/nri1391.
4. Allen, S.J., Crown, S.E., and Handel, T.M. 2007. Chemokine: receptor structures, interactions, and antagonism [online]. Available from http://arjounrals.annulareviews.org/doi/abs/10.1146/annurev.immunol.24.021605. 090529 [accessed 3 January 2007].
5. Bernstein, D.I., Cartier, A., Cote, J., Malo, J.L., Boulet, L.P., Wanner, M., et al. 2002. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am. J. Respir. Crit. Care Med. 166: 445-450. doi:10.1164/rccm.2109018.
6. Bolte, G., Bischof, W., Borte, M., Lehmann, I., Wichmann, H.E., and Heinrich, J. 2003. Early endotoxin exposure and atopy development in infants: results of a birth cohort study. Clin. Exp. Allergy, 33: 770-776. doi:10.1046/j.1365-2222.2003.01665.x.
7. Bourke, E., Bosisio, D., Golay, J., Polentarutti, N., and Mantovani, A. 2003. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood, 102: 956-963. doi:10.1182/blood-2002-11-3355.
8. Braun-Fahrlander, C., Riedler, J., Herz, U., Eder, W., Waser, M., Grize, L., et al. 2002. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347: 869-877. doi:10.1056/NEJMoa020057.
9. Campbell, J.D., Gangur, V., Simons, F.E., and HayGlass, K.T. 2004. Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. FASEB J. 18: 329-331.
10. Coelho, A.L., Hogaboam, C.M., and Kunkel, S.L. 2005. Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev. 16: 553-560. doi:10.1016/j.cytogfr.2005.03.004.
11. Devaney, J.M., Greene, C.M., Taggart, C.C., Carroll, T.P., O'Neill, S.J., and McElvaney, N.G. 2003. Neutrophil elastase upregulates interleukin-8 via toll-like receptor 4. FEBS Lett. 544: 129-132. doi:10.1016/S0014-5793(03) 00482-4.
12. Ding, A., Hwang, S., Lander, H.M., and Xie, Q.W. 1995. Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-kappa B. J. Leukoc. Biol. 57: 174-179.
13. Dragomir, E., and Simionescu, M. 2006. Monocyte Chemoattractant Protein-1 - a major contributor to the inflammatory process associated with diabetes. Arch. Physiol. Biochem. 112: 239-244. doi:10.1080/13813450601094672.
14. Dudziak, D., Kamphorst, A.O., Heidkamp, G.F., Buchholz, V.R., Trumpfheller, C., Yamazaki, S., et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science, 315: 107-111. doi:10.1126/science.1136080.
15. Eisenbarth, S.C., Piggott, D.A., Huleatt, J.W., Visintin, I., Herrick, C.A., and Bottomly, K. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196: 1645-1651. doi:10.1084/jem.20021340.
16. Fortier, A.H. 2003. Current protocols in immunology. Unit 14.4. Activation of murine macrophages. John Wiley & Sons, Hoboken, N.J.
17. Gangur, V., Simons, F.E., and HayGlass, K.T. 1998. Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-gamma over IL-4 responses. FASEB J. 12: 705-713.
18. Gehring, U., Bischof, W., Fahlbusch, B., Wichmann, H.E., and Heinrich, J. 2002. House dust endotoxin and allergic sensitization in children. Am. J. Respir. Crit. Care Med. 166: 939-944. doi:10.1164/rccm.200203-256OC.
19. Gereda, J.E., Leung, D.Y., Thatayatikom, A., Streib, J.E., Price, M.R., Klinnert, M.D., et al. 2000. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet, 355: 1680-1683. doi:10.1016/S0140-6736(00)02239-X.
20. Giles, R., and Loberg, R.D. 2006. Can we target the chemokine network for cancer therapeutics? Curr. Cancer Drug Targets, 6: 659-670. doi:10.2174/156800906779010245.
21. Hartl, D., Buckland, K.F., and Hogaboam, C.M. 2006a. Chemokines in allergic aspergillosis - from animal models to human lung diseases. Inflamm. Allergy Drug Targets, 5: 219-228.
22. Hartl, D., Latzin, P., Zissel, G., Krane, M., Krauss-Etschmann, S., and Griese, M. 2006b. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 173: 1370-1376. doi:10.1164/rccm.200508-1271OC.
23. Herrick, C.A., and Bottomly, K. 2003. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3: 405-412. doi:10.1038/nri1084.
24. John, M., Oltmanns, U., Binder, C., Meiners, S., Gellert, K., Chung, K.F., et al. 2004. Inhibition of chemokine production from human airway smooth muscle cells by fluticasone, budesonide and beclomethasone. Pulm. Pharmacol. Ther. 17: 41-47.
25. Kaisho, T., and Akira, S. 2006. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117: 979-987. Quiz 988. doi:10.1016/j.jaci.2006.02.023.
26. Kaza, V., Bandi, V., and Guntupalli, K.K. 2007. Acute severe asthma: recent advances. Curr. Opin. Pulm. Med. 13: 1-7.
27. Kline, J.N., Cowden, J.D., Hunninghake, G.W., Schutte, B.C., Watt, J.L., Wohlford-Lenane, C.L., et al. 1999. Variable airway responsiveness to inhaled lipopolysaccharide. Am. J. Respir. Crit. Care Med. 160: 297-303.
28. Ko, F.W., Lau, C.Y., Leung, T.F., Wong, G.W., Lam, C.W., Lai, C.K., et al. 2006. Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients. Clin. Exp. Allergy, 36: 44-51. doi:10.1111/j.1365-2222.2006.02398.x.
29. Konsman, J.P., Drukarch, B., and Van Dam, A.M. 2007. (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin. Sci. (Lond.), 112: 1-25.
30. Leung, T.F., Wong, G.W., Ko, F.W., Lam, C.W., and Fok, T.F. 2004. Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma. Clin. Exp. Allergy, 34: 786-791. doi:10.1111/j.1365-2222.2004.1951.x.
31. Liu, A.H., and Leung, D.Y. 2006. Renaissance of the hygiene hypothesis. J. Allergy Clin. Immunol. 117: 1063-1066. doi:10.1016/j.jaci.2006.03.027.
32. Michel, O., Ginanni, R., Le Bon, B., Content, J., Duchateau, J., and Sergysels, R. 1992. Inflammatory response to acute inhalation of endotoxin in asthmatic patients. Am. Rev. Respir. Dis. 146: 352-357.
33. Mond, J.J., and Brunswick, M. 2003. Current protocols in immunology - Unit 3.10 - Proliferative assays for B cell function. John Wiley & Sons, Inc., Hoboken, N.J.
34. Nagai, Y., Garrett, K.P., Ohta, S., Bahrun, U., Kouro, T., Akira, S., et al. 2006. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity, 24: 801-812. doi:10.1016/j. immuni.2006.04.008.
35. Pilette, C., Francis, J.N., Till, S.J., and Durham, S.R. 2004. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge. Eur. Respir. J. 23: 876-884.
36. Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 282: 2085-2088. doi:10.1126/science.282.5396.2085.
37. Qi, H., Denning, T.L., and Soong, L. 2003. Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles. Infect. Immun. 71: 3337-3342. doi:10.1128/IAI.71.6.3337-3342.2003.
38. Qian, C., An, H., Yu, Y., Liu , S., and Cao, X. 2007. TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation. Blood 109: 3308-3315. doi:10.1182/blood-2006-08-040337.
39. Rebenko-Moll, N.M., Liu, L., Cardona, A., and Ransohoff, R.M. 2006. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr. Opin. Immunol. 18: 683-689.
40. Ritter, M., Goggel, R., Chaudhary, N., Wiedenmann, A., Jung, B., Weith, A., et al. 2005. Elevated expression of TARC (CCL17) and MDC (CCL22) in models of cigarette smoke-induced pulmonary inflammation. Biochem. Biophys. Res. Commun. 334: 254-262. doi:10.1016/j.bbrc.2005.06.084.
41. Rizzo, M.C., Naspitz, C.K., Fernandez-Caldas, E., Lockey, R.F., Mimica, I., and Sole, D. 1997. Endotoxin exposure and symptoms in asthmatic children. Pediatr. Allergy Immunol. 8: 121-126. doi:10.1111/j.1399-3038.1997. tb00164.x.
42. Romagnani, P., Maggi, L., Mazzinghi, B., Cosmi, L., Lasagni, L., Liotta, F., et al. 2005. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. J. Allergy Clin. Immunol. 116: 1372-1379. doi:10.1016/j.jaci.2005.09.035.
43. Simpson, A., John, S.L., Jury, F., Niven, R., Woodcock, A., Ollier, W.E., et al. 2006. Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am. J. Respir. Crit. Care Med. 174: 386-392. doi:10.1164/rccm.200509-1380OC.
44. Steinman, R.M., and Hemmi, H. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311: 17-58.
45. Sukkar, M.B., Xie, S., Khorasani, N.M., Kon, O.M., Stanbridge, R., Issa, R., et al. 2006. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J. Allergy Clin. Immunol. 118: 641-648. doi:10.1016/j.jaci.2006.05.013.
46. Sultzer, B.M. 1968. Genetic control of leucocyte responses to endotoxin. Nature, 219: 1253-1254. doi:10.1038/2191253a0.
47. Sun, D., Chen, D., Du, B., and Pan, J. 2005. Heat shock response inhibits NF-kappaB activation and cytokine production in murine Kupffer cells. J. Surg. Res. 129: 114-121. doi:10.1016/j.jss.2005.05.028.
48. Szalai, C., Kozma, G.T., Nagy, A., Bojszko, A., Krikovszky, D., Szabo, T., et al. 2001. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J. Allergy Clin. Immunol. 108: 375-381. doi:10.1067/mai.2001.117930.
49. Tavernier, G., Fletcher, G., Gee, I., Watson, A., Blacklock, G., Francis, H., et al. 2006. IPEADAM study: indoor endotoxin exposure, family status, and some housing characteristics in English children. J. Allergy Clin. Immunol. 117: 656-662. doi:10.1016/j.jaci.2005.12.1311.
50. Ten Klooster, J.P., and Hordijk, P.L. 2007. Targeting and localized signalling by small GTPases. Biol. Cell, 99: 1-12.
51. Thorne, P.S., Kulhankova, K., Yin, M., Cohn, R., Arbes, S.J., Jr., and Zeldin, D.C. 2005. Endotoxin exposure is a risk factor for asthma: the national survey of endotoxin in United States housing. Am. J. Respir. Crit. Care Med. 172: 1371-1377. doi:10.1164/rccm.200505-758OC.
52. Uematsu, S., and Akira, S. 2006. The role of Toll-like receptors in immune disorders. Expert Opin. Biol. Ther. 6: 203-214. doi:10.1517/14712598.6.3.203.
53. Vercelli, D. 2006. Mechanisms of the hygiene hypothesis-molecular and otherwise. Curr. Opin. Immunol. 18: 733-737. doi:10.1016/j.coi.2006.09. 002.
54. Walsh, G.M. 2006. Targeting airway inflammation: novel therapies for the treatment of asthma. Curr. Med. Chem. 13: 3105-3111. doi:10.2174/ 092986706778521779.
55. Wang, Q., Tang, X.N., and Yenari, M.A. 2007. The inflammatory response in stroke. J. Neuroimmunol. 184: 53-68. doi:10.1016/j.jneuroim.2006.11.014.
56. Yao, T.C., Wu, K.C., Chung, H.T., Shaw, C.K., Kuo, M.L., Wu, C.J., et al. 2004. MCP-1 gene regulatory region polymorphism in Chinese children with mild, moderate and near-fatal asthma. Allergy, 59: 436-441. doi:10.1111/j.1398-9995.2003.00438.x.
57. Ying, S., Zhang, G., Gu, S., and Zhao, J. 2006. How much do we know about atopic asthma: where are we now? Cell Mol. Immunol. 3: 321-332.
58. Zietz, B., Buchler, C., Herfarth, H., Muller-Ladner, U., Spiegel, D., Scholmerich, J., et al. 2005. Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A→G promoter polymorphism. Diabetes Obes. Metab. 7: 570-578. doi:10.1111/j.1463-1326.2004.00436.x.
59. Zlotnik, A. 2006. Chemokines and cancer. Int. J. Cancer, 119: 2026-2029. doi:10.1002/ijc.22024.
60. Zlotnik, A., and Yoshie, O. 2000. Chemokines: a new classification system and their role in immunity. Immunity, 12: 121-127. doi:10.1016/S1074- 7613(00)80165-X.